Deutsche Bank analyst George Hill lowered the firm’s price target on GoodRx (GDRX) to $8 from $9 and keeps a Hold rating on the shares post the Q3 report.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.